Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, May 2026, Jun 2026, Jul 2026, Sep 2026 and Oct 2026.
- Largest single sale: $932K (23,333 shares) of Royalty Pharma plc on Dec 1, 2025. Filing
- Last sale before this period: Feb 22, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Royalty Pharma plc (RPRX) | EVP, Research & Investments | Dec 31, 2020 | Oct 5, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 5, 2026, Royalty Pharma plc: sold 4,126 shares for $236K, under a disclosed plan. 1 filing: 1
- Sep 28, 2026, Royalty Pharma plc: sold 4,126 shares for $239K, under a disclosed plan. 1 filing: 1
- Aug 5, 2026, Royalty Pharma plc: 8,252 shares awarded. 1 filing: 1
- Jul 1, 2026, Royalty Pharma plc: sold 9,099 shares for $508K, under a disclosed plan. 1 filing: 1
- Jun 24, 2026, Royalty Pharma plc: sold 9,098 shares for $502K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.